MabCure, Inc. Stock Price

OTCPK:MBCI Community·US$78.1k Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

MBCI Share Price Performance

US$0.0001

0.00 (0.00%)

US$0.0001

0.00 (0.00%)

US$0.0001

Mon, 12 Jan 26

Share Pricen/a

MBCI Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

MabCure, Inc. Key Details

Last Reported Earnings

Dec 31, 2011

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About MBCI

Founded: 2006
Employees: n/a
CEO: Jehu Thomas Hand
Website: n/a

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.